2013
DOI: 10.4155/fmc.13.6
|View full text |Cite
|
Sign up to set email alerts
|

P2X and P2Y Nucleotide Receptors as Targets in Cardiovascular Disease

Abstract: Endogenous nucleotides have widespread actions in the cardiovascular system, but it is only recently that the P2X and P2Y receptor subtypes, at which they act, have been identified and subtype-selective agonists and antagonists developed. These advances have greatly increased our understanding of the physiological and pathophysiological functions of P2X and P2Y receptors, but investigation of the clinical usefulness of selective ligands is at an early stage. Nonetheless, the evidence considered in this review … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 146 publications
0
26
0
Order By: Relevance
“…In both studies, one group of agonists caused the cytoplasmic end of helix VI of the receptor to move, shifting the equilibrium towards G protein coupling, whilst another group moved the cytoplasmic end of helix VII, leading to binding of β-arrestin to the receptor. P2Y receptors are activated by endogenous nucleotides, such as adenosine 5′-triphosphate (ATP) and uridine 5′-triphosphate (UTP) [6][7][8], but there are few reports of biased agonism. ATP and UTP induce differential interaction of the human P2Y 2 receptor with β-arrestins and the downstream increase in phosphorylation of ERK elicited by UTP was transient, whereas the response to ATP was prolonged [9].…”
Section: Introductionmentioning
confidence: 99%
“…In both studies, one group of agonists caused the cytoplasmic end of helix VI of the receptor to move, shifting the equilibrium towards G protein coupling, whilst another group moved the cytoplasmic end of helix VII, leading to binding of β-arrestin to the receptor. P2Y receptors are activated by endogenous nucleotides, such as adenosine 5′-triphosphate (ATP) and uridine 5′-triphosphate (UTP) [6][7][8], but there are few reports of biased agonism. ATP and UTP induce differential interaction of the human P2Y 2 receptor with β-arrestins and the downstream increase in phosphorylation of ERK elicited by UTP was transient, whereas the response to ATP was prolonged [9].…”
Section: Introductionmentioning
confidence: 99%
“…For example, we found a highly significant down-regulation of the beta 1 adrenergic receptor (ADRB1) in 19/21 groups, which is well known for its crucial role in heart function and down-regulation in heart failure [36-38]. Other interesting candidates for in depth analysis were predicted, like P2Y receptor subunits, a receptor class expressed in various heart cells and regulating cardiovascular function in health and disease [39-46]. We also found a high significance for sphingosine-1-phospate receptor 3 (S1PR3) being down-regulated in 14/14 groups.…”
Section: Resultsmentioning
confidence: 99%
“…P2Y receptors have been heavily investigated in the context of thrombosis and heart disease, and P2X receptors have been studied in the context of inflammatory and psychological disorders and in bone homeostasis. This is an exciting time in the nucleotide receptor field as there is growing interest in the potential translational possibilities of exploiting the P2X and P2Y receptors (Lenertz et al, 2011; Barn and Steinhubl, 2012; Kennedy et al, 2013). …”
Section: Nucleotide Receptor Overviewmentioning
confidence: 99%